ID   GA45G_HUMAN             Reviewed;         159 AA.
AC   O95257; Q5VZ87; Q9C076;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   18-JUN-2025, entry version 181.
DE   RecName: Full=Growth arrest and DNA damage-inducible protein GADD45 gamma;
DE   AltName: Full=Cytokine-responsive protein CR6;
DE   AltName: Full=DNA damage-inducible transcript 2 protein;
DE            Short=DDIT-2;
GN   Name=GADD45G; Synonyms=CR6, DDIT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9827804; DOI=10.1016/s0092-8674(00)81619-0;
RA   Takekawa M., Saito H.;
RT   "A family of stress-inducible GADD45-like proteins mediate activation of
RT   the stress-responsive MTK1/MEKK4 MAPKKK.";
RL   Cell 95:521-530(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10597261; DOI=10.1038/sj.onc.1203054;
RA   Fan W., Richter G., Cereseto A., Beadling C., Smith K.A.;
RT   "Cytokine response gene 6 induces p21 and regulates both cell growth and
RT   arrest.";
RL   Oncogene 18:6573-6582(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Jung N., Yi Y., Kim D., Shong M., Hong S., Lee H., Bae I.;
RT   "Cloning and characterization of Gadd45 gamma gene and its regulation by
RT   C/EBP.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-112.
RX   PubMed=10773677; DOI=10.1159/000015496;
RA   Gong R., Yu L., Zhang H., Tu Q., Zhao Y., Yang J., Xu Y., Zhao S.;
RT   "Assignment of human GADD45G to chromosome 9q22.1-->q22.3 by radiation
RT   hybrid mapping.";
RL   Cytogenet. Cell Genet. 88:95-96(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-112.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH GADD45GIP1.
RC   TISSUE=Colon carcinoma;
RX   PubMed=12716909; DOI=10.1074/jbc.m212835200;
RA   Chung H.K., Yi Y.-W., Jung N.-C., Kim D., Suh J.M., Kim H., Park K.C.,
RA   Song J.H., Kim D.W., Hwang E.S., Yoon S.-H., Bae Y.-S., Kim J.M., Bae I.,
RA   Shong M.;
RT   "CR6-interacting factor 1 interacts with Gadd45 family proteins and
RT   modulates the cell cycle.";
RL   J. Biol. Chem. 278:28079-28088(2003).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS), SUBUNIT, MUTAGENESIS OF ALA-47;
RP   ILE-76; LEU-80; ALA-83; GLU-87 AND ASP-89, AND INTERACTION WITH PCNA.
RX   PubMed=22058036; DOI=10.1007/s13238-011-1090-6;
RA   Zhang W., Fu S., Liu X., Zhao X., Zhang W., Peng W., Wu C., Li Y., Li X.,
RA   Bartlam M., Zeng Z.H., Zhan Q., Rao Z.;
RT   "Crystal structure of human Gadd45gamma reveals an active dimer.";
RL   Protein Cell 2:814-826(2011).
CC   -!- FUNCTION: Involved in the regulation of growth and apoptosis. Mediates
CC       activation of stress-responsive MTK1/MEKK4 MAPKKK.
CC   -!- SUBUNIT: Undergoes concentration-dependent homodimerization, which is
CC       required for growth inhibititory activity and enhances interaction with
CC       PCNA. Interacts with GADD45GIP1. Interacts with PCNA.
CC       {ECO:0000269|PubMed:12716909, ECO:0000269|PubMed:22058036}.
CC   -!- INTERACTION:
CC       O95257; P12814: ACTN1; NbExp=3; IntAct=EBI-448202, EBI-351710;
CC       O95257; Q8TED9: AFAP1L1; NbExp=8; IntAct=EBI-448202, EBI-1053644;
CC       O95257; Q9BPX5: ARPC5L; NbExp=4; IntAct=EBI-448202, EBI-711189;
CC       O95257; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-448202, EBI-10181188;
CC       O95257; Q6QNY1: BLOC1S2; NbExp=3; IntAct=EBI-448202, EBI-465872;
CC       O95257; Q9P2H0: CEP126; NbExp=2; IntAct=EBI-448202, EBI-473176;
CC       O95257; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-448202, EBI-10181988;
CC       O95257; Q96MT7: CFAP44; NbExp=3; IntAct=EBI-448202, EBI-12551219;
CC       O95257; Q92600-3: CNOT9; NbExp=3; IntAct=EBI-448202, EBI-12907584;
CC       O95257; Q13561: DCTN2; NbExp=5; IntAct=EBI-448202, EBI-715074;
CC       O95257; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-448202, EBI-742054;
CC       O95257; Q9H0I2: ENKD1; NbExp=5; IntAct=EBI-448202, EBI-744099;
CC       O95257; Q8NDB6: FAM156A; NbExp=3; IntAct=EBI-448202, EBI-749727;
CC       O95257; Q8TAE8: GADD45GIP1; NbExp=4; IntAct=EBI-448202, EBI-372506;
CC       O95257; Q6IC98: GRAMD4; NbExp=3; IntAct=EBI-448202, EBI-10962409;
CC       O95257; Q92993: KAT5; NbExp=2; IntAct=EBI-448202, EBI-399080;
CC       O95257; Q5T3J3: LRIF1; NbExp=4; IntAct=EBI-448202, EBI-473196;
CC       O95257; Q9Y6R4: MAP3K4; NbExp=3; IntAct=EBI-448202, EBI-448104;
CC       O95257; Q9Y3C7: MED31; NbExp=2; IntAct=EBI-448202, EBI-394707;
CC       O95257; P08949-2: NMB; NbExp=3; IntAct=EBI-448202, EBI-12302085;
CC       O95257; A6NK89: RASSF10; NbExp=3; IntAct=EBI-448202, EBI-6912267;
CC       O95257; Q15293: RCN1; NbExp=3; IntAct=EBI-448202, EBI-948278;
CC       O95257; Q04864: REL; NbExp=4; IntAct=EBI-448202, EBI-307352;
CC       O95257; Q9Y3A4: RRP7A; NbExp=3; IntAct=EBI-448202, EBI-7223720;
CC       O95257; P57060: RWDD2B; NbExp=15; IntAct=EBI-448202, EBI-724442;
CC       O95257; Q99598: TSNAX; NbExp=4; IntAct=EBI-448202, EBI-21353855;
CC       O95257; Q9BVJ6: UTP14A; NbExp=3; IntAct=EBI-448202, EBI-473284;
CC       O95257; Q8N3J9: ZNF664; NbExp=3; IntAct=EBI-448202, EBI-2799450;
CC       O95257; Q0D2J5: ZNF763; NbExp=3; IntAct=EBI-448202, EBI-10226414;
CC   -!- DOMAIN: Two central helices mediate homodimerization through parallel
CC       packing.
CC   -!- SIMILARITY: Belongs to the GADD45 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=GADD45G entry;
CC       URL="https://en.wikipedia.org/wiki/GADD45G";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF078078; AAC83329.1; -; mRNA.
DR   EMBL; AF079806; AAD28544.1; -; mRNA.
DR   EMBL; AF265659; AAF73468.1; -; Genomic_DNA.
DR   EMBL; AF087883; AAK00414.1; -; mRNA.
DR   EMBL; AK313689; BAG36438.1; -; mRNA.
DR   EMBL; BT007234; AAP35898.1; -; mRNA.
DR   EMBL; AF494037; AAM00007.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62774.1; -; Genomic_DNA.
DR   EMBL; BC000465; AAH00465.1; -; mRNA.
DR   EMBL; BC019325; AAH19325.1; -; mRNA.
DR   CCDS; CCDS6686.1; -.
DR   RefSeq; NP_006696.1; NM_006705.4.
DR   PDB; 2WAL; X-ray; 2.40 A; A/B=1-159.
DR   PDB; 3FFM; X-ray; 2.30 A; A=1-159.
DR   PDBsum; 2WAL; -.
DR   PDBsum; 3FFM; -.
DR   AlphaFoldDB; O95257; -.
DR   SMR; O95257; -.
DR   BioGRID; 116117; 78.
DR   CORUM; O95257; -.
DR   DIP; DIP-24218N; -.
DR   FunCoup; O95257; 2507.
DR   IntAct; O95257; 61.
DR   MINT; O95257; -.
DR   STRING; 9606.ENSP00000252506; -.
DR   BioMuta; GADD45G; -.
DR   PaxDb; 9606-ENSP00000252506; -.
DR   PeptideAtlas; O95257; -.
DR   ProteomicsDB; 50751; -.
DR   Antibodypedia; 13541; 896 antibodies from 35 providers.
DR   DNASU; 10912; -.
DR   Ensembl; ENST00000252506.11; ENSP00000252506.6; ENSG00000130222.11.
DR   GeneID; 10912; -.
DR   KEGG; hsa:10912; -.
DR   MANE-Select; ENST00000252506.11; ENSP00000252506.6; NM_006705.4; NP_006696.1.
DR   UCSC; uc004aqq.4; human.
DR   AGR; HGNC:4097; -.
DR   CTD; 10912; -.
DR   DisGeNET; 10912; -.
DR   GeneCards; GADD45G; -.
DR   HGNC; HGNC:4097; GADD45G.
DR   HPA; ENSG00000130222; Tissue enhanced (heart muscle, liver).
DR   MIM; 604949; gene.
DR   OpenTargets; ENSG00000130222; -.
DR   VEuPathDB; HostDB:ENSG00000130222; -.
DR   eggNOG; ENOG502RXKU; Eukaryota.
DR   GeneTree; ENSGT00950000182964; -.
DR   HOGENOM; CLU_118164_0_0_1; -.
DR   InParanoid; O95257; -.
DR   OMA; SRSAYDW; -.
DR   OrthoDB; 5976967at2759; -.
DR   PAN-GO; O95257; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; O95257; -.
DR   PathwayCommons; O95257; -.
DR   SignaLink; O95257; -.
DR   SIGNOR; O95257; -.
DR   BioGRID-ORCS; 10912; 18 hits in 1153 CRISPR screens.
DR   ChiTaRS; GADD45G; human.
DR   EvolutionaryTrace; O95257; -.
DR   GeneWiki; GADD45G; -.
DR   GenomeRNAi; 10912; -.
DR   Pharos; O95257; Tbio.
DR   PRO; PR:O95257; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; O95257; protein.
DR   Bgee; ENSG00000130222; Expressed in mucosa of stomach and 122 other cell types or tissues.
DR   ExpressionAtlas; O95257; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; IBA:GO_Central.
DR   FunFam; 3.30.1330.30:FF:000018; growth arrest and DNA damage-inducible protein GADD45 gamma; 1.
DR   Gene3D; 3.30.1330.30; -; 1.
DR   InterPro; IPR024824; GADD45.
DR   InterPro; IPR029064; Ribosomal_eL30-like_sf.
DR   InterPro; IPR004038; Ribosomal_eL8/eL30/eS12/Gad45.
DR   PANTHER; PTHR10411; GROWTH ARREST AND DNA DAMAGE-INDUCIBLE PROTEIN GADD45; 1.
DR   PANTHER; PTHR10411:SF4; GROWTH ARREST AND DNA DAMAGE-INDUCIBLE PROTEIN GADD45 GAMMA; 1.
DR   Pfam; PF01248; Ribosomal_L7Ae; 1.
DR   SUPFAM; SSF55315; L30e-like; 1.
DR   neXtProt; NX_O95257; -.
DR   PharmGKB; PA28512; -.
DR   TreeFam; TF300196; -.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Developmental protein; Differentiation;
KW   Reference proteome.
FT   CHAIN           1..159
FT                   /note="Growth arrest and DNA damage-inducible protein
FT                   GADD45 gamma"
FT                   /id="PRO_0000148336"
FT   REGION          43..86
FT                   /note="Homodimerization"
FT   VARIANT         112
FT                   /note="G -> S (in dbSNP:rs3138505)"
FT                   /evidence="ECO:0000269|PubMed:10773677, ECO:0000269|Ref.7"
FT                   /id="VAR_018888"
FT   MUTAGEN         47
FT                   /note="A->R: 30-fold reduction in homodimerization affinity
FT                   and 90% decrease in growth inhibition activity and ability
FT                   to stop cell cycle; when associated with E-77, E-80 and
FT                   R-83."
FT                   /evidence="ECO:0000269|PubMed:22058036"
FT   MUTAGEN         76
FT                   /note="I->E: 30-fold reduction in homodimerization affinity
FT                   and 90% decrease in growth inhibition activity and ability
FT                   to stop cell cycle; when associated with R-47, E-80 and
FT                   R-83."
FT                   /evidence="ECO:0000269|PubMed:22058036"
FT   MUTAGEN         80
FT                   /note="L->E: 30-fold reduction in homodimerization affinity
FT                   and 90% decrease in growth inhibition activity and ability
FT                   to stop cell cycle; when associated with R-47, E-77 and
FT                   R-83."
FT                   /evidence="ECO:0000269|PubMed:22058036"
FT   MUTAGEN         83
FT                   /note="A->R: 30-fold reduction in homodimerization affinity
FT                   and 90% decrease in growth inhibition activity and ability
FT                   to stop cell cycle; when associated with R-47, E-77 and
FT                   E-80."
FT                   /evidence="ECO:0000269|PubMed:22058036"
FT   MUTAGEN         87
FT                   /note="E->K: Reduced growth inhibition activity; when
FT                   associated with K-89."
FT                   /evidence="ECO:0000269|PubMed:22058036"
FT   MUTAGEN         89
FT                   /note="D->K: Reduced growth inhibition activity; when
FT                   associated with K-87."
FT                   /evidence="ECO:0000269|PubMed:22058036"
FT   CONFLICT        34..35
FT                   /note="QR -> HG (in Ref. 4; AAK00414)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        113..115
FT                   /note="APG -> CAC (in Ref. 4; AAK00414)"
FT                   /evidence="ECO:0000305"
FT   HELIX           17..35
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   STRAND          39..42
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   HELIX           43..52
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   HELIX           54..56
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   STRAND          57..63
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   HELIX           66..68
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   HELIX           72..87
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   STRAND          91..96
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   HELIX           98..105
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   STRAND          118..123
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   STRAND          125..128
FT                   /evidence="ECO:0007829|PDB:3FFM"
FT   HELIX           133..147
FT                   /evidence="ECO:0007829|PDB:3FFM"
SQ   SEQUENCE   159 AA;  17121 MW;  26427E5881941E64 CRC64;
     MTLEEVRGQD TVPESTARMQ GAGKALHELL LSAQRQGCLT AGVYESAKVL NVDPDNVTFC
     VLAAGEEDEG DIALQIHFTL IQAFCCENDI DIVRVGDVQR LAAIVGAGEE AGAPGDLHCI
     LISNPNEDAW KDPALEKLSL FCEESRSVND WVPSITLPE
//
